Late-breaking results from the FUSION trial, an investigator-initiated study using computed tomography (CT)-derived fractional flow reserve (FFR)—known as Heartflow FFRct (Heartflow)—for the diagnosis of patients with stable coronary artery disease (CAD), found that use of the artificial intelligence (AI)-derived technology reduced rates invasive coronary angiography by 44% compared to assessment using coronary computed tomography angiography […] The post ESC 2026: CT-derived fractional flow reserve helps reduce rates of invasive angiography in stable CAD patients appeared first on Cardiovascular News .